Clinical Trials Logo

Transplanted Heart Complication clinical trials

View clinical trials related to Transplanted Heart Complication.

Filter by:
  • None
  • Page 1

NCT ID: NCT03405831 Recruiting - Clinical trials for Cardiac Allograft Vasculopathy

Effect of Ivabradine on Exercise Capacity After Heart Transplantation

VANISH-CAV
Start date: April 17, 2018
Phase: Phase 4
Study type: Interventional

This study evaluates whether treatment with ivabradine compared to placebo can improve exercise capacity in long-term heart transplant recipients with cardiac allograft vasculopathy and elevated heart rate at rest. Patients will receive treatment with either ivabradin or placebo for a period of 12 weeks.